DUSP22 and Parkinson disease: In vitro experiments reveal that its overexpression inhibits the activation and differentiation of CD4+ T cells toward Th1/Th17 phenotypes, while its silencing has the opposite effect, suggesting that restoring JKAP could be a promising strategy to rebalance the immune response in PD (73).